Company intelligence / Profile preview
Oramed Pharmaceuticals Inc.
Jerusalem, Jerusalem District, Israeloramed.com ↗
- Ownership
- Public · ORMP
- Employees
- ~30
- Development stage
- Phase 3
01
Overview
Oramed Pharmaceuticals developed a proprietary oral protein/peptide drug delivery platform. Its flagship product, an oral insulin capsule for type 2 diabetes, reached Phase 3 trials under FDA oversight but did not meet its primary endpoint in January 2023. The company continues to develop additional pipeline candidates—including an oral GLP‑1 analog capsule and a joint venture developing an oral COVID‑19 vaccine—leveraging its POD™ technology to transform injectable therapies into convenient oral formulations.
- Therapeutic areas
- GastroenterologyEndocrinologyMetabolic DisordersInfectious Diseases
- Modalities
- Proteins (oral delivery)Peptides (oral delivery)Small molecules (potentially, via platform extension)
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
03
Partnerships
Premas Biotech Pvt. Ltd. – Partner in Oravax Medical JV for the development of the oral COVID–19 vaccine
04
Financials
- Market cap
- $161.8M
- Total revenue
- $2M
- Enterprise value
- $111.9M
Beyond the preview
Go deeper on Oramed Pharmaceuticals Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oramed Pharmaceuticals Inc..